Subscribe

DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is with the Department of Internal Medicine, Division of Neurology, Greenville Health System, Neuroscience Associates, in Greenville, South Carolina. Innov Clin Neurosci. 2017;14(3–4):38–40.

Read More
Managing Your Aging Patient Population

by Ann L. McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Innov Clin Neurosci. 2017;14(3–4)41–44. This ongoing column is dedicated to providing information to

Read More
Letter to the editor: Modafinil Augmentation Therapy in Patient with Traumatic Brain Injury

Innov Clin Neurosci. 2017;14(3–4):11 Dear Editor: Traumatic brain injury (TBI) is a significant cause of morbidity and mortality. Annually, more than two million people in the United States will sustain

Read More
Editor’s Message: Issue Highlights, January–February 2017

Dear Colleagues: Welcome to the January–February 2017 issue of Innovations in Clinical Neuroscience. We start our 14th year of publication strong with an interesting and diverse issue we hope you

Read More
Virtual Reality and Medical Inpatients: A Systematic Review of Randomized, Controlled Trials

by Julieta Dascal, BA; Mark Reid, PhD; Waguih William Ishak, MD, FAPA; Brennan Spiegel, MD, FACG; Jennifer Recacho, MA; Bradley Rosen, MD; and Itai Danovitch, MD, MBA All authors are

Read More
Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs

by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar, PhD; Suzanne Hendrix, PhD; Enchi Liu, PhD; David A. Loewenstein, PhD; Glenn Morrison, MSc, PhD; Leslie Shinobu, PhD; Keith Wesnes,

Read More